Complete the following form to download your document.
CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG)
Ingredients + Specialties from Univar Solutions is proud to carry Dow’s complete line of CARBOWAX™ SENTRY™ Polyethylene Glycols.
Dow’s fully integrated global supply chain combined with I + S from Univar Solutions’ vast network of facilities and private fleet provides you with reliable sourcing of this Active Pharmaceutical Ingredient & Excipient. Our technical and product development support experts are on hand to help ensure your pharmaceutical products comply with regulations and provide the best patient experience.
Prescription (Rx) and over-the-counter (OTC) drugs sold in North America are formulated with compendial ingredients like CARBOWAX™ SENTRY™ PEGs.
PEG forms available
Monographs available
I + S from Univar Solutions is the premier distributor of pharmaceutical ingredients in North America
- Vast network includes over 70 FDA-registered sites in North America
- Efficient private fleet with dedicated drivers servicing local regions
- Partnership with world class pharmaceutical ingredient manufacturers
- Experienced technical sales force with broad ingredient and industry knowledge
- Application development assistance available
Industry Applications
Chemical Manufacturing
- Chemical intermediates
- Processing aids
Food
- Indirect food contact under select FDA regulations in Title 21 of the Code of Federal Regulations (CFR)
Personal Care
- Face, neck and body lotions and creams
- Toothpastes
- Oral gels or rinses
- Medicated shampoos and conditioners
- Bar soaps
- Deodorant sticks
- Insect repellent sticks
- Bath salts
- Effervescent tablets
Pharmaceuticals
- Actives for laxatives and colonic lavages
- Excipients for liquid solutions and suspensions
- Hard and soft gelatin capsules
- Immediate and controlled release tablets
- Coated tablets
- Ointments
- Lotions
- Creams
- Gels
- Suppositories
The pharmaceutical and consumer health industry face significant challenges as most of the APIs in their pipelines have low solubility. These compounds often exhibit poor bioavailability and limited therapeutic effects, necessitating advanced formulation techniques to enhance their solubility and hence, their efficacy. Dow PEGs and MPEGs deliver unmatched solubility performance and continue to be trusted in countless prescription and over-the-counter drug formulations. Low aldehyde grades are also available, providing more flexibility in formulation design.
Product Information
Products Available
| Product Name | INCI | Supplier | Grade | Package Type | Weight | Billing Price | Price (Package) | |
|---|---|---|---|---|---|---|---|---|
| CARBOWAX MPEG 550 SENTRY, NF Grade, Liquid, Drum | -- | Dow Inc. | NF | Drum | 490.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol 400 NF Low Aldehyde | PEG-8 | Dow Inc. | NF | Drum | 515.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX SENTRY MPEG 350, NF Grade, Liquid, Drum | -- | Dow Inc. | NF | Drum | 490.09 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol 1000, NF-Kosher Grade, Liquid, 500 lb Drum | PEG-20 | Dow Inc. | NF | Drum | 500.01 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol 300, NF-EP-Kosher Grade, Liquid, 515 lb Drum | PEG-6 | Dow Inc. | NF | Drum | 515.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG) 400 NF | PEG-8 | Dow Inc. | NF | Drum | 515.02 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol 540 Inhibited, NF-Kosher Grade, Semi-solid, 500 lb Drum | -- | Dow Inc. | NF | Drum | 500.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol 600, NF-EP-Kosher Grade, Liquid, 500 lb Drum | PEG-12 | Dow Inc. | NF | Drum | 500.01 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| PEG 300 CARBOWAX SENTRY IBC700 | PEG-6 | Dow Inc. | NF | IBC | 2,499.82 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| PEG 300 CARBOWAX SENTRY, NF Grade, Liquid, Bulk | PEG-6 | Dow Inc. | NF | Bulk | 0.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG) 400 NF | PEG-8 | Dow Inc. | NF | Bulk | 0.00 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
| CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG) 400 NF | PEG-8 | Dow Inc. | NF | IBC | 2,424.87 lbs | -- |
Request Quote
|
-- |
|
|
||||||||
Video
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Fusce quis posuere arcu, ut mollis ex. Aenean tincidunt arcu vitae neque maximus rutrum. Nam non ex lacus. Maecenas vestibulum maximus diam eget convallis. Etiam sit amet odio id nulla rhoncus pellentesque. Ut in dui nunc. Fusce finibus condimentum mattis. Vivamus euismod augue sit amet consequat interdum. Vestibulum sodales neque quis molestie ullamcorper.
Additional Content
This is an article up to 100 characters
This is an additional description. Up to 275 characters of descriptive text about the content.
This is an article up to 100 characters
This is an additional description. Up to 275 characters of descriptive text about the content.
This is an article up to 100 characters
This is an additional description. Up to 275 characters of descriptive text about the content.
Resources
Medical Applications Policy
NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS:
Dow does not support or intend for its products to be used in: long-term or permanent contact with internal bodily fluids or tissues. “Long-term” is contact which exceeds 29 calendar days; use in cardiac prosthetic devices regardless of the length of time involved (“cardiac prosthetic devices” include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass-assisted devices); use as a critical component in medical devices that support or sustain human life; or use specifically by pregnant women or in applications designed specifically to promote or interfere with human reproduction. use as an ingredient of a pharmaceutical injectable application.
Dow requests that customers considering use of Dow products in medical applications notify Dow so that appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer to determine that the Dow product is safe, lawful, and technically suitable for the intended use.
DOW MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Dow does not support or intend for its products to be used in: long-term or permanent contact with internal bodily fluids or tissues. “Long-term” is contact which exceeds 29 calendar days; use in cardiac prosthetic devices regardless of the length of time involved (“cardiac prosthetic devices” include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass-assisted devices); use as a critical component in medical devices that support or sustain human life; or use specifically by pregnant women or in applications designed specifically to promote or interfere with human reproduction. use as an ingredient of a pharmaceutical injectable application.
Dow requests that customers considering use of Dow products in medical applications notify Dow so that appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer to determine that the Dow product is safe, lawful, and technically suitable for the intended use.
DOW MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Disclaimer
Get in touch, 24 hours a day, 7 days a week.
